Ashleigh Herriott

554 total citations
6 papers, 407 citations indexed

About

Ashleigh Herriott is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ashleigh Herriott has authored 6 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 1 paper in Genetics. Recurrent topics in Ashleigh Herriott's work include PARP inhibition in cancer therapy (4 papers), DNA Repair Mechanisms (3 papers) and Cell death mechanisms and regulation (2 papers). Ashleigh Herriott is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), DNA Repair Mechanisms (3 papers) and Cell death mechanisms and regulation (2 papers). Ashleigh Herriott collaborates with scholars based in United Kingdom, United States and India. Ashleigh Herriott's co-authors include Nicola J. Curtin, Miranda Patterson, John A. Glaspy, Johann S. de Bono, Saeed Rafii, Ramesh K. Ramanathan, Rashmi Chugh, David C. Smith, Lauren A. Byers and Lida A. Mina and has published in prestigious journals such as Cancer Discovery, Oncotarget and Molecular Cancer Therapeutics.

In The Last Decade

Ashleigh Herriott

5 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashleigh Herriott United Kingdom	4	359	255	74	59	57	6	407
Kate Sleeth United Kingdom	6	265 0.7×	372 1.5×	54 0.7×	68 1.2×	32 0.6×	9	440
Marie K. Classon Canada	2	238 0.7×	295 1.2×	36 0.5×	93 1.6×	36 0.6×	2	401
Jessie Jeffery Australia	8	155 0.4×	346 1.4×	37 0.5×	85 1.4×	63 1.1×	8	435
Paul W.G. Wijnhoven United Kingdom	7	221 0.6×	394 1.5×	46 0.6×	38 0.6×	34 0.6×	10	433
Carole Tirapo France	4	345 1.0×	342 1.3×	159 2.1×	156 2.6×	57 1.0×	4	517
Aditi Gulati United Kingdom	7	247 0.7×	358 1.4×	29 0.4×	67 1.1×	47 0.8×	11	464
Samuel E. Jones United Kingdom	8	208 0.6×	450 1.8×	36 0.5×	68 1.2×	38 0.7×	8	529
Shamima Yeasmin Japan	10	115 0.3×	289 1.1×	26 0.4×	123 2.1×	42 0.7×	19	442
Nicholas Badham United Kingdom	2	185 0.5×	271 1.1×	24 0.3×	46 0.8×	26 0.5×	2	328
Etienne Müller France	7	82 0.2×	117 0.5×	63 0.9×	59 1.0×	44 0.8×	9	215

Countries citing papers authored by Ashleigh Herriott

Since Specialization

Citations

This map shows the geographic impact of Ashleigh Herriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashleigh Herriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashleigh Herriott more than expected).

Fields of papers citing papers by Ashleigh Herriott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashleigh Herriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashleigh Herriott. The network helps show where Ashleigh Herriott may publish in the future.

Co-authorship network of co-authors of Ashleigh Herriott

This figure shows the co-authorship network connecting the top 25 collaborators of Ashleigh Herriott. A scholar is included among the top collaborators of Ashleigh Herriott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashleigh Herriott. Ashleigh Herriott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Matheson, Elizabeth, Ashleigh Herriott, Angelika Kaufmann, et al.. (2019). Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types. Cancers. 11(3). 354–354. 13 indexed citations

2.

Bono, Johann S. de, Ramesh K. Ramanathan, Lida A. Mina, et al.. (2017). Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers. Cancer Discovery. 7(6). 620–629. 314 indexed citations

3.

Middleton, Fiona K., Miranda Patterson, Sarah Fordham, et al.. (2015). Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition. Oncotarget. 6(32). 32396–32409. 47 indexed citations

4.

Herriott, Ashleigh, Susan J. Tudhope, Miranda Patterson, et al.. (2015). PARP1 expression, activity andex vivosensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia. Oncotarget. 6(41). 43978–43991. 29 indexed citations

5.

Henshaw, Joshua W., Huiyu Zhou, Ashleigh Herriott, et al.. (2013). Abstract A220: Inhibition of PBMC PARP activity with the novel PARP 1/2 inhibitor BMN 673 in patients with advanced solid tumors.. Molecular Cancer Therapeutics. 12(11_Supplement). A220–A220. 1 indexed citations

6.

Herriott, Ashleigh, Michèle Sweeney, Michael Whitaker, Michael J. Taggart, & Jun-Yong Huang. (2012). Kinetochore localized Mad2 and Cdc20 is itself insufficient for triggering the mitotic checkpoint when Mps1 is low inDrosophila melanogasterneuroblasts. Cell Cycle. 11(24). 4650–4660. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact